217303-06-5

Upstream product

• 762-42-5 dimethyl acetylenedicarboxylate 
• 217319-31-8 1-Ethyl-7-methoxy-2-(4-methoxyphenyl)-indolizine 
• 622-39-9 2-propylpyridine 
• 217303-02-1 4-nitro-2-propylpyridine-N-oxide 
• 217303-03-2 4-methoxy-2-n-propylpyridine-N-oxide 
• 217303-04-3 4-methoxy-2-n-propylpyridine 
• 20609-07-8 2-propyl-pyridine N-oxide 

Downstream Products

• 217303-07-6 4-ethyl-6-methoxy-3-(4-methoxyphenyl)pyrrolo[2,1,5-cd]indolizine-1,2-dicarboxylic acid 
• 217318-36-0 4-acetyl-1-ethyl-6-methoxy-2-(4-methoxyphenyl)pyrrolo[2,1,5-cd]indolizine 
• 217318-34-8 1-ethyl-6-hydroxy-2-(4-hydroxyphenyl)pyrrolo[2,1,5-cd]indolizine 
• 217318-33-7 1-ethyl-6-methoxy-2-(4-methoxyphenyl)pyrrolo[2,1,5-cd]indolizine 

Relevant academic research and scientific papers

Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives

A series of pyrrolo[2,1,5-cd]indolizine derivatives has been synthesized and evaluated as ligands for the estrogen receptor. Properly substituted mono- and di-hydroxy derivatives showed binding in the low nanomolar range in accordance with their structural resemblance to estrogen. (C) 2000 Elsevier Science Ltd.

Pyrrolo [2,1,5-cd] indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

The present invention relates to therapeutically active compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.

Pyrrolo[2,1,5-cd]indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

The present invention relates to therapeutically active compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.